Six weeks on Mounjaro and no weight loss: what the scales aren't telling you

The biggest misconception: that week six is the moment to judge

The most common thing people tell themselves at this point is that Mounjaro has failed them. It almost certainly hasn't. The six-week mark usually coincides with being on 2.5mg or, for some, having just moved to 5mg. At 2.5mg the medicine's job is to lower the chance of side effects as your gut and appetite signals adapt, it is not the dose that produced the results seen in clinical trials. The SURMOUNT-1 trial published in the New England Journal of Medicine reported around 20–21% average body-weight reduction at the 15mg maintenance dose over 72 weeks. The operative words are maintenance dose and 72 weeks. Judging an outcome at week six on the starting dose is, genuinely, measuring the wrong thing at the wrong time. Let that expectation go and replace it with a clearer picture of what the timeline actually looks like.

If you had similar concerns at an earlier point, the pattern and likely explanations we cover on the page about three weeks with no movement are still relevant here.

What is actually happening in your body at this stage

Even when the scales are unmoved, several things can be in flux. Tirzepatide activates both GIP and GLP-1 receptors, slowing gastric emptying and reshaping appetite signals. As those effects build, many people experience changes in fluid retention, bowel habits and activity levels, all of which affect scale weight independently of fat loss. Someone who was constipated before starting and whose digestion has now normalised may temporarily show a small weight increase. Someone who has started walking more since beginning treatment may be gaining a small amount of muscle while losing fat, with the net scale number barely moving. None of this means the medicine is ineffective. The weight changes that typically follow week six tend to become more visible as doses increase and appetite suppression strengthens.

One other thing worth knowing: some people respond earlier and more dramatically at lower doses, while others need the higher doses to see meaningful progress. Neither pattern is wrong. Prescribers look at the direction of change over months, not a single weigh-in at a fixed early week.

When six weeks with no change does need a closer look

There is a difference between slow early progress and a genuine signal that something needs reviewing. Contact your prescriber if you have had no weight change at all over six weeks and you are already on 5mg or above, or if you are experiencing side effects that have made it difficult to eat normally, significant nausea or diarrhoea can mask what's happening and can also affect how reliably the medicine is absorbed. The NHS tirzepatide patient information covers gastrointestinal effects and explains when to seek advice. A prescriber may want to check whether your injection technique, storage, and rotation of injection sites are all correct, since any of those can reduce efficacy, and it is also worth understanding what 2ml of tirzepatide represents as a volume so you can confirm you are drawing up and administering the right amount. For cost and access context if you are weighing whether to continue, the Mounjaro treatment overview explains what private treatment includes. Separately, the typical changes in the first four weeks page sets a useful baseline if you want to compare your early experience against what others report.

NICE's appraisal of tirzepatide (TA1026) sets the clinical review point at six months at the highest tolerated dose, with a threshold of 5% weight loss. Six weeks is well before that window, which is reason for patience rather than alarm.

Practical steps while you wait for dose increases to take effect

A few things genuinely move the needle during the early weeks. Protein intake matters more on this medicine than most people expect, higher protein helps preserve muscle as appetite falls, and that matters for long-term metabolic rate. Hydration affects both the side-effect profile and energy levels; the nausea many people feel at 2.5mg is often worse when they are even mildly dehydrated. Alcohol blunts appetite regulation in ways that can work against the medicine. And strength-based activity, even light resistance work, supports the body-composition changes you are aiming for. None of this replaces the dose increases that drive most of the weight change, but they make the difference between steady progress and a frustrating plateau once titration moves forward. If you have questions about your individual plan, the clinical team at nume reviews every case personally and can advise on what to expect at your current stage.